Zhang Y, Wan Y, Li J, Ju S, Tong X, Wu J
Front Immunol. 2025; 16:1556509.
PMID: 40070828
PMC: 11894379.
DOI: 10.3389/fimmu.2025.1556509.
Laun S, Pierre F, Kim S, Lunz D, Maddala T, Braun J
Diagnostics (Basel). 2024; 14(18).
PMID: 39335682
PMC: 11431466.
DOI: 10.3390/diagnostics14182003.
Laun S, Kann L, Braun J, Gilbert S, Lunz D, Pierre F
Am J Gastroenterol. 2024; .
PMID: 39140473
PMC: 11825890.
DOI: 10.14309/ajg.0000000000003030.
Zhao Y, Zhao H, Zhao M, Yu Y, Qi X, Wang J
World J Gastroenterol. 2024; 30(20):2638-2656.
PMID: 38855150
PMC: 11154680.
DOI: 10.3748/wjg.v30.i20.2638.
Ahuja P, Yadav R, Goyal S, Yadav C, Ranga S, Kadian L
Cell Biol Toxicol. 2023; 39(6):2437-2465.
PMID: 37338772
DOI: 10.1007/s10565-023-09818-5.
The 8th Wonder of the Cancer World: Esophageal Cancer and Inflammation.
Chela H, Gangu K, Ertugrul H, Al Juboori A, Daglilar E, Tahan V
Diseases. 2022; 10(3).
PMID: 35892738
PMC: 9326664.
DOI: 10.3390/diseases10030044.
Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on mA Regulators.
Li J, Zhu H, Yang Q, Xiao H, Wu H, Fang Z
J Oncol. 2022; 2022:5490461.
PMID: 35069736
PMC: 8776445.
DOI: 10.1155/2022/5490461.
DNA methylation markers in esophageal cancer: an emerging tool for cancer surveillance and treatment.
Wang H, DeFina S, Bajpai M, Yan Q, Yang L, Zhou Z
Am J Cancer Res. 2021; 11(11):5644-5658.
PMID: 34873485
PMC: 8640794.
CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification.
Liang Y, Mao Q, Wang L, Xia W, Chen B, Wang H
Clin Transl Med. 2021; 11(9):e519.
PMID: 34586741
PMC: 8473481.
DOI: 10.1002/ctm2.519.
Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.
Lin L, Cheng X, Yin D
Front Oncol. 2020; 10:549850.
PMID: 33194605
PMC: 7645039.
DOI: 10.3389/fonc.2020.549850.
ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.
Vrana D, Hlavac V, Brynychova V, Vaclavikova R, Neoral C, Vrba J
Int J Mol Sci. 2018; 19(3).
PMID: 29543757
PMC: 5877729.
DOI: 10.3390/ijms19030868.
Role of methylation in esophageal cancer carcinogenesis and its clinical significance.
Li J, Ye D, Wang L, Peng Y, Li Q, Deng H
Onco Targets Ther. 2018; 11:651-663.
PMID: 29440913
PMC: 5798571.
DOI: 10.2147/OTT.S154999.
Expression of methylation-modulated tumor-related genes in endoscopically resected early esophageal squamous neoplasia.
Hosoda K, Yashima K, Tamoto A, Yamamoto S, Kawata S, Ikebuchi Y
Oncol Lett. 2017; 14(1):737-742.
PMID: 28693228
PMC: 5494775.
DOI: 10.3892/ol.2017.6196.
Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.
Wu D, Chen X, Xu Y, Wang H, Yu G, Jiang L
Oncol Lett. 2017; 13(4):2745-2750.
PMID: 28454461
PMC: 5403441.
DOI: 10.3892/ol.2017.5759.
mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.
Luo J, Wang W, Tang Y, Zhou D, Gao Y, Zhang Q
J Cancer. 2017; 8(4):646-656.
PMID: 28367244
PMC: 5370508.
DOI: 10.7150/jca.15652.
NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
Chen X, Yang Y, Liu J, Li B, Xu Y, Li C
Oncotarget. 2017; 8(5):8105-8119.
PMID: 28042954
PMC: 5352386.
DOI: 10.18632/oncotarget.14099.
The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
Ma K, Cao B, Guo M
Clin Epigenetics. 2016; 8:43.
PMID: 27110300
PMC: 4840959.
DOI: 10.1186/s13148-016-0210-9.
Emerging therapeutic targets in esophageal adenocarcinoma.
Gaur P, Hunt C, Pandita T
Oncotarget. 2016; 7(30):48644-48655.
PMID: 27102294
PMC: 5217045.
DOI: 10.18632/oncotarget.8777.
Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
Zhu J, Ling Y, Xu Y, Lu M, Liu Y, Zhang C
Int J Clin Exp Pathol. 2016; 8(11):14392-400.
PMID: 26823755
PMC: 4713541.
Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity.
Ahrens T, Timme S, Ostendorp J, Bogatyreva L, Hoeppner J, Hopt U
Lab Invest. 2015; 96(3):307-16.
PMID: 26692290
DOI: 10.1038/labinvest.2015.148.